Chromatography
Application of exact mass ms in bioanalysis discovery quantitation with uplc and xevo qtof ms
Mar 01 2010
Author: Robert S. Plumb and Marian Twohig on behalf of Waters Corporation
The quantification of candidate pharmaceuticals and/or their metabolites in biological fluids plays a key role in drug discovery. The information generated is used to determine key pharmacokinetics parameters such as clearance, half-life, Tmax, and bioavailability. During discovery ADME studies the metabolic fate of the molecule is determined as well as its pharmacokinetics. Currently this involves using two analytical instruments: one to provide the quantitative information and one for the qualitative analysis. Quantitative information is normally derived from a tandem quadrupole instrument due to sensitivity; qualitative data is gathered either from an ion trap or quadrupole time-of-flight MS (QTof) instrument. This need for multiple instruments and analytical runs results in reduced productivity and increased instrument capital costs. QTof technology is well-recognized as the platform of choice for exact mass MS/MS structural elucidation.1-3 However, its use in quantitative DMPK studies has yet to be fully exploited. In this application note, we present the use of a high-sensitivity QTof mass spectrometer coupled with UltraPerformance LC® (UPLC®) separation technology for the quantitative analysis of a model candidate pharmaceutical at the levels of sensitivity required for drug discovery.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark
Aug 28 2024 Phnom Penh, Cambodia